Delivery Order SPE2DR25D3017-SPE2DR26F3DV7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,359.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml), a diabetes medication. The contract was executed as a firm fixed price delivery order on June 25, 2025, with an ultimate completion date of June 26, 2025, and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,907.40 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This is a firm fixed price delivery order with no set-aside designation, executed under a competitive award process. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,966.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 7, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,292.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,832.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $37,490.02 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage), a diabetes medication. The contract is a firm fixed-price delivery order with no set-aside designation, issued on October 15, 2025, and scheduled for completion by October 16, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3DV7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,759.08 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication. This competitively awarded, firm fixed-price delivery order was finalized on November 18, 2025, with completion expected by November 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this contract action, indicating it was competed among qualified vendors in the open market. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999 million and extending through December 2026. This prime vehicle enables AmerisourceBergen to supply comprehensive pharmaceutical and medical products globally to support military healthcare programs, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA, delivering critical medical commodities ranging from specialty medications and vaccines to medical devices and diagnostic supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/18/25 |